Vertex issued first U.S. patent for IMPDH inhibitors, begins phase II trials of lead inhibitor Sep. 23, 1998
Licensing and/or CRADA opportunity: drug and method to prevent and treat graft-vs.-host disease Sep. 8, 1998
RSS